Medicare Enrolled

Dr. Dana Biermann Flynn, D.O.

Pediatrics · Wenonah, NJ
Low-engagement
1050 MANTUA PIKE, Wenonah, NJ 08090
8568530848
In practice since 2008 (17 years)
NPI: 1265697429 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Biermann Flynn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Biermann Flynn? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Biermann Flynn

Dr. Dana Biermann Flynn is a pediatrics specialist in Wenonah, NJ, with 17 years of NPI registration.

Between the years covered by Open Payments, Dr. Biermann Flynn received a total of $806 from 18 pharmaceutical and/or device companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatrics. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Biermann Flynn is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice $806 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$806
Total received (2018-2024)
Avg $115/year across 7 years
Top 16% in NJ for pediatrics
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
54
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$806 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$159
2023
$167
2022
$112
2021
$149
2020
$52
2019
$75
2018
$93

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Hologic Sales and Service, LLC
$62
Corium, LLC
$35
IRONSHORE PHARMACEUTICALS INC.
$28
Cranial Technologies, Inc
$21
PFIZER INC.
$13
Top 3 companies account for 78.6% of 2024 payments
All-time payments by company (2018-2024) ›
Ironshore Pharmaceuticals Inc.
$102
Tris Pharma Inc
$100
PFIZER INC.
$99
Cranial Technologies, Inc
$71
GlaxoSmithKline, LLC.
$67
Hologic Sales and Service, LLC
$62
SANOFI PASTEUR INC.
$55
Corium, LLC
$51
Supernus Pharmaceuticals, Inc.
$34
IRONSHORE PHARMACEUTICALS INC.
$28
Adlon Therapeutics L.P.
$27
ARBOR PHARMACEUTICALS, INC.
$25
Hologic, LLC
$17
Neos Therapeutics, LP
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
kaleo, Inc.
$14
Sanofi Pasteur Inc.
$12
AstraZeneca Pharmaceuticals LP
$12
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
ADHANSIA XR · APTIMA · AUVI-Q · Aptima STI · Azstarys · BEXSERO · BEYFORTUS · Cotempla XR-ODT · Doc Band · Dyanavel XR · Evekeo · FLUZONE QUADRIVALENT · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · MENACTRA · PREVNAR - 13 · PREVNAR 13 · QELBREE · QUILLICHEW ER · Quillivant · Quillivant XR · SYNAGIS · TRUMENBA · VAXELIS · VYVANSE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pediatrics specialist in Wenonah?
Compare pediatricians in the Wenonah area by procedure volume, costs, and industry payment transparency.
Browse pediatricians nearby

Geographic Context

Pediatricians within 10 mi
2,487
Per 100K population
816.7
County median income
$102,807
Nearest hospital
NORTHBROOK BEHAVIORAL HEALTH HOSPITAL
5.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Biermann Flynn is a pediatrics specialist, with low-engagement industry engagement in the top 16% of NJ peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Biermann Flynn receive payments from pharmaceutical companies?
Yes. Dr. Biermann Flynn received a total of $806 from 18 companies across 54 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Biermann Flynn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →